TY - JOUR
T1 - Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9
AU - Awaya, N.
AU - Takao, M.
AU - Natsuda, H.
AU - Yamawaki, T.
AU - Suzuki, N.
AU - Takayama, N.
AU - Ishida, A.
AU - Kawai, Y.
PY - 1995/11
Y1 - 1995/11
N2 - A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.
AB - A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.
UR - http://www.scopus.com/inward/record.url?scp=0029401550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029401550&partnerID=8YFLogxK
M3 - Article
C2 - 8691572
AN - SCOPUS:0029401550
SN - 0485-1439
VL - 36
SP - 1300
EP - 1304
JO - [Rinshō ketsueki] The Japanese journal of clinical hematology
JF - [Rinshō ketsueki] The Japanese journal of clinical hematology
IS - 11
ER -